Northwestern Medicine scientists have developed the first animal model for ALS dementia, a form of ALS that also damages the brain, allowing for direct monitoring of test drugs to determine if they work.
Northwestern Medicine scientists developed the first blood test to diagnose major depression in adults and to predict who will benefit from cognitive behavioral therapy.
Mary J.C. Hendrix, PhD, revealed a variance in signaling pathways in embryonic stem cells and metastatic melanoma cells that may impact new therapeutic strategies in cancer.
A study analyzed data from 82,000 women to see how stressful life events and social strain affect future development of coronary heart disease and stroke.
Northwestern Medicine scientists have discovered a novel cause of glaucoma in an animal model, and related to their findings, are now developing an eye drop aimed at curing the disease.
Northwestern Medicine scientists identified a previously unknown signaling pathway that enhances tumor growth in glioblastomas and head and neck cancers. The proteins in the pathway could be targeted in the treatment of human cancers.